Correction to: Nature Communications https://doi.org/10.1038/s41467-024-54003-9, published online 13 November 2024
In this article the author’s name Natalija Ivljanin was incorrectly written as Natalija Ivjanin. The original article has been updated.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Huré, JB., Foucault, L., Ghayad, L.M. et al. Author Correction: Pharmacogenomic screening identifies and repurposes leucovorin and dyclonine as pro-oligodendrogenic compounds in brain repair. Nat Commun 16, 538 (2025). https://doi.org/10.1038/s41467-025-55864-4
Published:
DOI: https://doi.org/10.1038/s41467-025-55864-4
